期刊文献+

应用脱细胞血管基质构建组织工程血管的初步研究 被引量:8

Reconstruction of tissue engineering blood vessel via acellular matrix
暂未订购
导出
摘要 目的:采用脱细胞处理的猪胸主动脉血管基质作为支架材料,接种人脐带血管内皮细胞,构建组织工程血管。方法:以新鲜猪胸主动脉为原材料,1% Triton X-100为脱细胞试剂,制备脱细胞血管基质;采用冷冻干燥和热交联法对脱细胞血管基质进行改性,并进行组织学观察及力学性能测定。用人脐带内皮细胞经培养和扩增后,再与所制备的脱细胞血管基质进行复合培养,光学显微镜及扫描电镜观察内皮细胞生长状况。结果:1%TritonX-100处理84h的猪胸主动脉,既能完全脱除血管中细胞,同时又完整保留血管基质的三维结构;对脱细胞血管基质冷冻干燥24h,120℃下热交联12h,能有效提高材料的机械强度,断裂强度可达到1.70MPa。扫描电镜下可见,脱细胞血管基质与内皮细胞复合培养7d,已形成典型血管内膜样结构。结论:经改性后的脱细胞血管基质与内皮细胞具有良好的相容性,用其作为支架材料与内皮细胞复合培养,有望应用于构建组织工程化血管。 AIM : To reconstruct the tissue engineering blood vessel by using acellular matrix of porcine thoracic aorta tissue as the scaffold, and by ineculability of vascular endothelial cells (EC) from human umbilical cord vein. METHODS : The porcine thoracic aorta was treated with 1% Triton X - 100 for preparing acellular vessel matrix, and the mechanical characterization was in succession modified by freeze - drying and thermal cross - linking techniques. Meanwhile, the mechanics capability of the vessel was measured. The endothelial cells isolated from umbilical cord vein were seeded on the acellular matrix scaffolds by tissue culture in vitro. The structure of acellular matrix was analyzed by light mi- croscopy and scanning electron microscopy. RESULTS: By treatment with 1% Triton X - 100 for 84 h, the cells of thoracic aorta were fully come off and the three - dimensional structure of the matrix still remained. After modification by freeze - drying for 24 h and then thermal cross - linking under vacuum at 120 ℃ for 12 h, the tensile strength of the acellular matrix remarkable increased and reached the maximum breaking strength of 1.70 MPa. It was also showed that cultured endothelial cells grew on the surface of acellular matrix for 7 days and the typical structure of vessel - like intimal formation was observed under scanning electron microscopy. CONCLUSION: The acellular matrix and endothelial cells have favorable compatibility. The modified acellular matrix could be a good candidate scaffold for rebuilding the tissue engineering blood vessel.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第4期792-796,共5页 Chinese Journal of Pathophysiology
基金 广东省十五攻关重点资助项目(NoA302020104) 教育部生物医用高分子材料重点实验室(武汉大学)资助课题
关键词 脱细胞基质 内皮细胞 组织工程 血管 Acellular matrix Endothelial cells Tissue engineering Blood vessels
  • 相关文献

参考文献13

  • 1AUalre E, Bruneval P, Mandet C, et al. The immunogenicity of the extracellular matrix in arterial xenografts[ J]. Surgery, 1997, 122(1):73-81.
  • 2Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts [ J ]. Eur J Vasc Endovasc Surg, 2002, 23 (6) : 474 - 475.
  • 3Yow KH, Ingrarn J, Korossis SA, et al. Tissue engineering of vascular conduits[J]. Br J Surg, 2006,93 (6) : 652 -661.
  • 4Lee KY. Design parameters of polymers for tissue engineering applications [J]. Macromolecular Res, 2005, 13 (4) : 277 -284.
  • 5杨德业,张怀勤,季亢挺,黄晓燕,徐力辛,宋后燕.内皮祖细胞在体外培养成血管样结构的初步观察[J].中国病理生理杂志,2006,22(10):1970-1974. 被引量:10
  • 6Conconi MT, Nico B, Mangieri D, et al. Angiogenic response induced by acellular aortic matrix in vivo[J] Anat Rec A Discov Mol Cell Evol Biol, 2004, 281A (2) : 1303 - 1307.
  • 7Amiel GE, Komura M, Shapira O, et al. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells[J]. Tissue Eng, 2006, 12 (8) : 2355 - 2365.
  • 8Hoerstrup SP, Cummings Mrcs I, et al. Functional growth in tissue - engineered living, vascular grafts: follow - up at 100 weeks in a large animal model[J]. Circulation, 2006,114 (1) : 1159-1166.
  • 9Kim WG, Park JK, Lee WY. Tissue engineered heart valve leaflets: an effective method of obtaining acellularized valve xenografts [ J ]. Int J Artif Organs, 2002, 25 ( 8 ) : 791 - 797.
  • 10Korossis SA, Booth C, Wilcox HE,et al. Tissue engineering of cardiac valve prostheses Ⅱ: biomechanical characterization of decellularized porcine aortic heart valves[J]. Heart Valve Dis, 2002, 11(4) : 463 -471.

二级参考文献11

  • 1Asasaha T, Masuda H, Takahashi T, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275(5302): 964-967.
  • 2Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization [ J ]. Circ Res, 1999, 85 ( 3 ) :221 - 228.
  • 3Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood - derived endothelial progenitor cells augment postnatal neovascularization [ J]. J Clin Invest,2000, 105(11): 1527 -1536.
  • 4Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury[ J]. Circ Res, 2003,93(2) : e17 -e24.
  • 5Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia [ J ]. Circulation, 2001 ,103(5): 634 -637.
  • 6Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia [J]. Circulation, 2003, 107 ( 3 ) :461 -468.
  • 7Asahara T, Bauters C, Pastore C J, et al. Local delivery of growth factor endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon- injured rat carotid artery[ J]. Circulation,1995, 91( 11 ) : 2793 - 2801.
  • 8Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow - derived endothelial progenitor cells [ J ].EMBO J, 1999, 18(14) : 3964 -3972.
  • 9Flugelman MY, Dichek DA. Seeding of intracoronary stents with endothelial cells: current status and future prospects[ J]. J Interv Cardiol, 1995, 8 (4) : 383 -385.
  • 10Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood - derived human adult endothelial progenitor cells into functionally active cardiomyocytes[J]. Circulation, 2003, 107(7): 1024-1032.

共引文献9

同被引文献136

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部